Serious menstrual bleeding associated with use of TNF alpha blocker : two cases
Menstrual disorders associated with the use of TNF alpha blocker have been rarely reported. Herein, we reported two cases aged 31 and 41, presenting with excessive menstrual bleeding occured after adalimumab administration which was subsequently discontinued.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Rheumatology international - 32(2012), 7 vom: 20. Juli, Seite 2175-6 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bes, Cemal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4TI98Z838E |
|---|
| Anmerkungen: |
Date Completed 21.11.2012 Date Revised 20.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00296-010-1455-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM196971195 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM196971195 | ||
| 003 | DE-627 | ||
| 005 | 20231223205617.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00296-010-1455-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0657.xml |
| 035 | |a (DE-627)NLM196971195 | ||
| 035 | |a (NLM)20352221 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bes, Cemal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serious menstrual bleeding associated with use of TNF alpha blocker |b two cases |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.11.2012 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Menstrual disorders associated with the use of TNF alpha blocker have been rarely reported. Herein, we reported two cases aged 31 and 41, presenting with excessive menstrual bleeding occured after adalimumab administration which was subsequently discontinued | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 650 | 7 | |a Estradiol |2 NLM | |
| 650 | 7 | |a 4TI98Z838E |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 700 | 1 | |a Soy, Mehmet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d 1985 |g 32(2012), 7 vom: 20. Juli, Seite 2175-6 |w (DE-627)NLM012644315 |x 1437-160X |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2012 |g number:7 |g day:20 |g month:07 |g pages:2175-6 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00296-010-1455-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2012 |e 7 |b 20 |c 07 |h 2175-6 | ||